Introduction: Pain and functional impairment associated with joint disease are major
| INTRODUCTION
Joint bleeds, a common occurrence in individuals with hemophilia, often result in acute and chronic pain. Pain from joint bleeding may consequentially lead to functional impairment and is a major issue faced by people with hemophilia (PWH). In the Hemophilia Experiences, Results, and Opportunities (HERO) study, which explored healthrelated quality of life (HRQoL) in individuals with moderate or severe hemophilia A or B, 38% of respondents with hemophilia A and 42% of respondents with hemophilia B reported experiencing chronic pain related to hemophilia, 1 and 89% of respondents overall experienced pain that interfered with activities in the past 4 weeks. 2 Assessments of the impact of pain in PWH have indicated that pain and functional impairment may contribute to reduced HRQoL. [3] [4] [5] Although it is recognized that the evaluation of pain and its impact on quality of life in PWH is important, there is a need to standardize tools for assessing pain and the effects of pain in the clinical setting. 6, 7 The use of patient-reported outcome (PRO) instruments to evaluate the impact of pain on HRQoL in PWH has been inconsistent, and the utility of these tools in measuring hemophilia-related pain is not well established. The Pain, Functional Impairment, and Quality of Life (P-FiQ) study was a non-interventional assessment of pain and its impact on HRQoL in US adult males with hemophilia and a history of joint pain or bleeding. An important aim of the study was to validate the use of generic and hemophilia-specific PRO instruments in measuring pain, functional impairment, and HRQoL in PWH. Previous
reports from P-FiQ demonstrated validity 8, 9 and reliability 10, 11 of PRO instruments in this study population. In addition, significant differences in PRO scores and joint status as measured by the Hemophilia Joint Health Score v2.1 (HJHS) were observed between various known groups (eg, self-reported pain levels), also supporting sufficient known-group validity. 9 Although these previous reports highlight the feasibility of using PRO instruments in PWH, the analysis presented here determined whether variability in PRO scores and joint status was associated with certain characteristics of respondents such as age, employment status, and level of self-reported pain. A better understanding of how these characteristics are associated with PRO scores may help inform strategies in using these tools in individuals with hemophilia for personalizing management approaches.
| METHODS

| Participant recruitment/eligibility
The P-FiQ study was a cross-sectional, observational study of adult 
| PRO instruments
Participants completed a survey that included demographic informa- Complete descriptions of the PRO instruments administered in P-FiQ are provided elsewhere (Buckner et al in this supplement).
EQ-5D-5L is a generic PRO instrument that evaluates health status "today" and consists of 5 items that are each rated using 5 response levels, from which an index score is calculated. A separate section contains a 100-point VAS on which participants report their overall health; the scale ranges from 0 ("worst imaginable" health) to 100
("best imaginable" health). BPI assesses pain in the past 7 days and contains 2 sections: pain severity and pain interference; each section comprises multiple domains that are rated on a scale from 0 ("no pain" or "does not interfere") to 10 ("pain as bad as you can imagine" or "complete interference"). HAL measures functional ability over the past month across 7 domains. Three component scores (upper extremity activity, basic lower extremity activity, and complex lower extremity activity) and an overall sum score were calculated based on the domain scores. The HJHS was administered by a physical therapist to assess joints that are most commonly affected in individuals with hemophilia (eg, ankles, knees, and elbows). HJHS total scores range from 0 to 124, with higher scores indicating worse joint status.
| Statistical methods
We performed post hoc analyses of PRO scores to examine the dif- 
| RESULTS
| Patient and disease characteristics
The P-FiQ study enrolled a total of 381 men (aged ≥18 years) with hemophilia A or B and a history of joint pain or bleeding. A majority of participants (71%) had severe hemophilia (factor VIII/IX <1%). HJHS scores were available for 240 participants. Overall median age (Q1, Q3) of P-FiQ participants was 34 (26.3, 47.2) years. Most were employed (77%), and 65% were either overweight (36%) or obese (29%). Twenty percent reported experiencing acute pain in the past 6 months, 34% chronic pain, and 32% both acute and chronic pain. Fifty percent of participants had a history of joint procedures or surgery, 16% had HIV, and 51% had hepatitis C virus (HCV).
| PRO and HJHS scores by participant subgroups
For most characteristics, PRO scores varied across subgroups (Table 1) .
Differences in EQ-5D-5L index scores across participant subgroups were minimal. Characteristics consistently associated with worse pain and function included age (specifically, the age 45-<60 years subgroup), unemployment, comorbidities (including viral [HIV/HCV]), self-reporting symptoms (arthritis/bone/joint problems, both acute and chronic pain, and anxiety), severe hemophilia, and a history of joint procedures.
| EQ-5D-5L VAS by participant subgroups
Overall, HRQoL scores, as measured by EQ-5D-5L VAS, spanned the entire response range (0-100). Significant (P < 0.05) differences were observed among subgroups in several categories (Table 2) . Median 
| PRO scores by respondent education level
Across PRO instruments, respondents with a college education generally reported worse pain, function, and HRQoL outcomes than those 
| PRO scores by respondent employment status
Respondents who were not employed generally had worse pain, function, and HRQoL outcomes and higher HJHS scores 
| PRO scores by self-reported pain characteristics
Scores for PRO instruments were also compared across respondent- 
| PRO scores by self-reported anxiety/ depression
Scores for BPI, HAL, and HJHS were also compared between respondents who reported anxiety/depression and those who did not 
T A B L E 2 Subgroup analysis-EQ-5D-5L VAS scores n
EQ-5D-5L VAS
| DISCUSSION
This analysis of PRO scores across subgroups of P-FiQ respondents demonstrates that reduced HRQoL and poor joint health are consistently associated with certain demographic and clinical patient characteristics. In addition to other reports from P-FiQ regarding the validity and reliability of PROs and HJHS in adults with hemophilia, [8] [9] [10] [11] this analysis underscores the importance and potential utility of these instruments for evaluating HRQoL outcomes and joint status in individuals with hemophilia.
Self-reported anxiety or depression appeared to be most consistently associated with greater pain and functional impairment relative to the other subgroup comparisons that were explored in this analysis. This observation complements previous studies which found correlations between pain and depressive symptoms in the general (non-hemophilia) population and in other chronic conditions associated with pain. [17] [18] [19] Additionally, other studies have demonstrated high levels of clinical distress among people with bleeding disorders 20 and previous reports from P-FiQ indicated that respondents who experienced both acute and chronic pain in the last 6 months were more likely to report having depression (30% vs 0%-15% of those with no pain, acute pain only, or chronic pain only). 21 Taken together, these findings indicate that worse outcomes on PRO instruments may be interrelated and that high levels of pain may be an important contributing factor to self-reported anxiety/depression in some individuals with hemophilia. The association of pain and functional impairment with patient demographic and clinical characteristics, including anxiety/depression, through multivariate modeling is explored in greater depth in a parallel report from P-FiQ (Kempton et al in this supplement).
The EQ-5D-5L VAS, indicating a respondent's perception of his or her overall health status "today," was significantly lower among F I G U R E 3 PRO scores by respondent employment status older individuals, those who were unemployed, and those who had a history of joint procedures (likely a marker for more advanced hemophilic arthropathy), HIV/HCV, and other comorbidities.
Interestingly, no significant differences in the EQ-5D-5L VAS were seen across hemophilia severities (mild/moderate vs severe); however, this outcome may be expected to align more closely with clinical phenotype than with factor level, given the inclusion criteria requiring a history of joint pain or bleeding. Respondents who were employed had a higher median EQ-5D-5L index score, indicating better health status, than those who were not employed. This observation agrees with other studies evaluating quality of life in people with chronic disease, in which quality of life was increased in participants who were employed compared with those who were not employed. 22, 23 Joint disease, pain, and functional impairment were generally increased among participants who were college educated, those who further, that respondents reporting pain and disability were less likely to be employed. 2 Worse outcomes were consistently observed in respondents who self-reported both acute and chronic pain compared with respondents in the other pain subgroups (acute pain only, chronic pain only, or no pain). Of note, these data are supported by previous reports from the P-FiQ study regarding the ability of PRO instruments to discriminate among known groups, which demonstrated that responses to all 4 BPI pain severity items varied significantly among known pain groups (acute, chronic, or both). 9 Additional analysis from the P-FiQ study population regarding the validity of PRO instruments showed strong correlations between PRO scores measuring pain with those measuring physical function (eg, HAL overall score correlated with BPI worst pain, average pain, and current pain), demonstrating the association of functional impairment with pain. 8 The relationship between pain and function, as well as reduced joint health, is also illustrated in this analysis, as respondents reporting both acute and chronic pain had the lowest median HAL score and the highest median HJHS score compared with all other pain subgroups.
Results from the P-FiQ study are potentially limited in their extrapolation to the entire US hemophilia population, as participants were required to be men with hemophilia and a history of joint pain or bleeding. These results may therefore be specific to a population with a more severe phenotype and may not reflect those of the general hemophilia population. In addition, the requirement for a history of joint problems may limit the use of hemophilia severity as a covariate, contributing to a lack of observable differences in PRO scores across hemophilia severities in the P-FiQ study population. Further exploration into whether hemophilia severity (defined by baseline clotting factor activity level)
in part independently predicts pain and function beyond its impact on joint status is described elsewhere in this supplement (Kempton et al).
The cross-sectional design of the study also limits the assessment of changes in outcomes in response to various treatments over time.
| CONCLUSIONS
These findings demonstrate that certain groups of participants in the P-FiQ study vary in the results of the PROs assessed. These observations provide greater insight into how individual patient factors (eg, pain level, psychological problems) may affect factors that contribute 
